相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Biologics for Inflammatory Bowel Disease and Their Safety Pregnancy: A Systematic Review and Meta-analysis
Ole Haagen Nielsen et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)
Ustekinumab levels in pregnant women with inflammatory bowel disease and infants exposed in utero
Emma Flanagan et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2022)
Pregnancy and Neonatal Outcomes After Fetal Exposure to Biologics and Thiopurines Among Women With Inflammatory Bowel Disease
Uma Mahadevan et al.
GASTROENTEROLOGY (2021)
Vedolizumab clearance in neonates, susceptibility to infections and developmental milestones: a prospective multicentre population-based cohort study
Mette Julsgaard et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2021)
Differences in the placental pharmacokinetics of vedolizumab and ustekinumab during pregnancy in women with inflammatory bowel disease: a prospective multicentre study
Katarina Mitrova et al.
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2021)
Pregnancy outcomes in inflammatory bowel disease patients treated with vedolizumab, anti-TNF or conventional therapy: results of the European CONCEIVE study
Annick Moens et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2020)
P538 Pregnancy outcomes in women with psoriasis, psoriatic arthritis, Crohn’s disease and ulcerative colitis treated with ustekinumab
A Geldhof et al.
Journal of Crohns & Colitis (2020)
Safety of Anti-TNF-Alpha Therapy During Pregnancy on Longterm Outcome of Exposed Children: A Controlled, Multicenter Observation
Dana Duricova et al.
INFLAMMATORY BOWEL DISEASES (2019)
Inflammatory Bowel Disease in Pregnancy Clinical Care Pathway: A Report From the American Gastroenterological Association IBD Parenthood Project Working Group
Uma Mahadevan et al.
GASTROENTEROLOGY (2019)
Long-Term Safety of In Utero Exposure to Anti-TNFα Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY Study
M. Chaparro et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2018)
Use of Biologic Therapy by Pregnant Women With Inflammatory Bowel Disease Does Not Affect Infant Response to Vaccines
Dawn B. Beaulieu et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2018)
Concentrations of Adalimumab and Infliximab in Mothers and Newborns, and Effects on Infection
Mette Julsgaard et al.
GASTROENTEROLOGY (2016)
Pregnancy and newborn outcome of mothers with inflammatory bowel diseases exposed to anti-TNF-α therapy during pregnancy: three-center study
Martin Bortlik et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2013)